Chromatin states define tumour-specific T cell dysfunction and reprogramming

Philip, Mary, Fairchild, Lauren, Sun, Liping, Horste, Ellen L., Camara, Steven, Shakiba, Mojdeh, Scott, Andrew C., Viale, Agnes, Lauer, Peter, Merghoub, Taha, Hellmann, Matthew D., Wolchok, Jedd D., Leslie, Christina S., Schietinger, Andrea·2017·Nature

DOI 10.1038/nature22367

Cited by (934)

Items 701–800 of 934

Balancing Intrinsic and Extrinsic Factors in CD8 + T Cell Therapy
Dongwook Lee, Yoontae Lee · 2026 · Immune Network
T cell exhaustion landscapes and therapeutic modulation in cancer immunity
Jhommara Bautista, Andrés López‐Cortés · 2026 · Frontiers in Cell and Developmental Biology
2D Differential Metallic Immunopotentiators Drive High Diversity and Capability of Antigen‐specific Immunity Against Tumor
Hongze Ren, Anqi Zhu, Wei Yang, Yiwen Jia, Hui Cheng, Ye Wu, Zhengqi Tang, Weifan Ye, Mayu Sun, Yujie Xie et al. · 2024 · Advanced Science
Construction and validation of a regulatory T cells-based classification of renal cell carcinoma: an integrated bioinformatic analysis and clinical cohort study
Yuntao Yao, Yifan Liu, Bingnan Lu, Guo Ji, Lei Wang, Keqin Dong, Zihui Zhao, Donghao Lyu, Maodong Wei, Siqi Tu et al. · 2024 · Cellular Oncology
Immune regeneration: implications for cancer immunotherapy and beyond
Steven L. Reiner · 2025 · Journal of Clinical Investigation
Spatiotemporal Immune Landscape and Long-term Immune Memory in POLE-Mutant Endometrial Cancer at the Single-Cell Level
Koen Brummel, Marta Requesens, Nienke van Rooij, Hagma H. Workel, Florine A. Eggink, Annechien Plat, René Wardenaar, Diana C.J. Spierings, Floris Foijer, David N. Church et al. · 2025 · Cancer Immunology Research
Leukemia escapes immunity by imposing a type 1 regulatory program on neoantigen-specific CD4+ T cells
Hrishi Venkatesh, Enoc Granados Centeno, Qianyun Luo, Miriam Arroyo, Lynn M. Heltemes-Harris, Todd Philip Knutson, Yinjie Qiu, Allison Haaning, Beau R. Webber, Veronika Bachanová et al. · 2025 · Blood
CDK4/6 Inhibitor Priming Enhances PD‐1 Blockade via Sell hi Neutrophil‐Induced Stat5a + Progenitor Exhausted CD8 + T Cell
Yu Zhang, Bao Sun, Rong Zhou, Zizhen Gong, Yong Han, Wenjie Tao, Chaoji Shi, Wuchang Zhang, Laikui Liu, Zhiyuan Zhang et al. · 2025 · Advanced Science
Strategies for manufacturing cell therapy products aligned with patient needs
Prajna Guha, Steven C. Katz · 2022 · Methods in cell biology
Invariant NK T cells counteract HCC metastasis by mediating the migration of splenic CD4+ T cells into the white pulp and infiltration of B cells
Jinke Geng, Mengxiao Xie, Meina Yan, Xiaoyan Xie, Fuxin Wang, Rui Zhu, Mutian Han · 2025 · Communications Biology
Mechanisms of resistance to immune checkpoint inhibitors
Xiaojun Liu, Quanlin Guan · 2020 · World Chinese Journal of Digestology
493 Tired and hungry: a potential role for CD47 in T cell exhaustion
Levi Mark B Mangarin, Cailian Liu, Roberta Zappasodi, Pamela M. Holland, Jedd D. Wolchok, Taha Merghoub, Chien‐Huan Weng, Chien‐Huan Weng, David Schröder · 2020 · Regular and Young Investigator Award Abstracts
Treatment of refractory/relapsed extranodal NK/T cell lymphoma with decitabine plus anti-PD-1: A case report
Linjie Li, Junyu Zhang · 2022 · World Journal of Clinical Cases
Bacterial vaginosis-driven changes in cervicovaginal immunity that expand the immunological hypothesis for increased HIV susceptibility
Finn MacLean, Adino Tesfahun Tsegaye, Jessica B. Graham, Jessica L. Swarts, Sarah C. Vick, Nicole B. Potchen, Irene Cruz Talavera, Lakshmi Warrier, Julien Dubrulle, Lena K. Schroeder et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
Analysis of the Heterogeneity of the Tumor Microenvironment and the Prognosis and Immunotherapy Response of Different Immune Subtypes in Hepatocellular Carcinoma
Jian Hu, Feifei Mao, Lifang Li, Xiaoqian Wang, Depei Cai, Longmei He, Qian Wu, Cong Wang, Ning Zhang, Yanfen Ma et al. · 2022 · Journal of Oncology
CD39 identifies a specific CD8 + T cell population in lung adenocarcinoma-related metastatic pleural effusion
Lei-lei Lv, Hongbin Wang, Yao-xin Zhang, Jiawei Zhai, Yu Shen, Qiu‐Xia Qu, Cheng Chen · 2023 · BMC Immunology
Inference of Developmental Hierarchy and Functional States of Exhausted T Cells from Epigenetic Profiles with Deep Learning
Hongyan Chen, Dongxue Yan, Jie Sun, Meng Zhou · 2024 · Journal of Chemical Information and Modeling
Obacunone potentiated PD-1 immunotherapy in pancreatic cancer by mediating CD36
Chun‐Yan Sang, Jia-Rong Liu, Yi-Dan Zheng, Tian Chai, Jiao‐Tai Shi, Mohammad Reza Naghavi, Komila Alibekovna Eshbakova, Boymirzaev Azamat Solievich, Jun‐Li Yang · 2025 · European Journal of Pharmacology
Miniaturized scalable arrayed CRISPR screening in primary cells enables discovery at the single donor resolution
Miti A. Patel, Brittany P. Boribong, Hugo Sinha, Bin Xiao, Keqiang Xie, Philippe Q. N. Vo, Andrew B. Chin, Ayoub Ellouzi, Samuel R. Little, Steve C. C. Shih et al. · 2025 · Scientific Reports
CD4 + T cells facilitate the RT-induced abscopal effect by promoting antigen cross-presentation to CD8 + T cells at unirradiated tumor sites
Xi Rao, Kateryna Onyshchenko, Meidan Wang, Ren Luo, Xuanwei Zhang, Liqun Wang, Siegmar Kuhn, Yizhou Yang, Simone Gaedicke, Prof Anca-Ligia Grosu et al. · 2026 · Journal for ImmunoTherapy of Cancer
Integrating Three Functional Subsets of T Cell Immunity Into an Integrative Model for Cancer Immunotherapy
J O Park, Heeju Ryu · 2026 · Immune Network
Demethylation-primed tandem CD19/CD20 CAR T cells in relapsed/refractory B-cell lymphoma: a phase I/II trial
Chunmeng Wang, Yelei Guo, Fuxin Han, Yipeng Zhang, Chun Liu, Zhiqiang Wu, Chuan Tong, Qingming Yang, Yuting Lu, Yadi Zhong et al. · 2026 · Nature Communications
Cytotoxic lymphocyte heterogeneity in glioblastoma: insights from single-cell and spatial multiomics toward precision immunotherapeutic reprogramming
Wentao Dong, Yang Li, Zhuolin Wu, Quanlin Fu, Jinshuang Zhao, Bangyue Wang, Jia Yao, Chenglu Lu, Minfeng Tong · 2026 · Frontiers in Immunology
CAR T Cell Therapy in Solid Tumors: Lessons From Early‐Phase Clinical Trials and Biological Barriers to Efficacy
Kasie Liu, Vincent T. Pham, Shaozi Fu, Lu‐Zhe Sun, Gang Huang · 2026 · Hematological Oncology
The transcription factor IRF8 drives tumor-specific exhaustion in CD8+ T cells
Marco Ongaro, Romane Thouenon, Isaac Crespo, Alexandre Dumez, Mélanie Charmoy, Eduardo Roman Camacho, Victoria J. Morel, Daniela Cropp, Emma Desponds, Giulio Zanette et al. · 2026 · The Journal of Experimental Medicine
The road not taken en route to T cell exhaustion
Barsha Dash, Patrick G. Hogan · 2023 · Nature Immunology
Identification and validation of the clinical prediction model and biomarkers based on chromatin regulators in colon cancer by integrated analysis of bulk- and single-cell RNA sequencing data
Yichao Ma, Fang Fang, Kai Liao, Jingqiu Zhang, Wei Chen, Yiqun Liao, Bin Zhao, Yongkun Fang, Yuji Chen, Daorong Wang et al. · 2024 · Translational Cancer Research
The diversity of inhibitory receptor co-expression patterns of exhausted CD8+ T cells in oropharyngeal carcinoma
Yufang Rao, Ke Qiu, Yao Song, Minzi Mao, Lan Feng, Danni Cheng, Junhong Li, Ziyan Zhang, Yuyang Zhang, Xiuli Shao et al. · 2024 · iScience
Decoupling the correlation between cytotoxic and exhausted T lymphocyte states enhances melanoma immunotherapy response prediction
Binbin Wang, Kun Wang, Di Wu, Sahil Sahni, Peng Jiang, Eytan Ruppin · 2024 · iScience
Therapeutic and prognostic effect of disulfidptosis-related genes in lung adenocarcinoma
Changshuan Li, Chao Sun, Yakun Li, Lin Dong, Xian Wang, Ruixin Li, Junjie Su, Qiong Cao, Shiyong Xin · 2024 · Heliyon
Tumor-specific CXCR6 positive precursor CD8+ T cells mediate tumor control in metastatic melanoma
Yang Song, Ji Chen, Yaqin Zhang, Ning Wu, Yongjun Zhu, Gang Chen, Feng Miao, Zhiming Chen, Yiqing Wang · 2025 · Cellular Oncology
Enhancing the antitumor activity of CD19/BCMA CAR-T cells in vitro with a PD1IL7R chimeric switch receptor
Kai Yan, Zhongdang Xiao · 2025 · Cellular Immunology
Prime time for immunotherapy in advanced urothelial cancer
Di Jiang, Srikala S. Sridhar · 2018 · Asia-Pacific Journal of Clinical Oncology
Combining Epigenetic and Immunotherapy in Cancer: Molecular Mechanisms
Anna Meiliana, Andi Wijaya · 2023 · The Indonesian Biomedical Journal
Epigenetic programming of the immune responses in cancer
Abbey A. Saadey, Amir Yousif, Hazem E. Ghoneim · 2021 · Elsevier eBooks
Lipotoxicity as a Barrier for T Cell-Based Therapies
Romy Loschinski, Judit Rial Saborido, Martin Böttcher, Sascha Kahlfuß, Dimitrios Mougiakakos · 2022 · Biomolecules
Commentary: Small Molecule Inhibition of PD-1 Transcription is an Effective Alternative to Antibody Blockade in Cancer Therapy
Alison Taylor, Christopher E. Rudd · 2019 · Journal of Immunological Sciences
An endogenous glucocorticoid-cytokine signaling circuit promotes CD8 + T cell dysfunction in the tumor microenvironment
Nandini Acharya, Asaf Madi, Huiyuan Zhang, Max Klapholz, Elena Christian, Karen Olivia Dixon, Geoffrey G. Fell, Katherine Tooley, Davide Mangani, Junrong Xia et al. · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
Three-dimensional genome structure and chromatin accessibility reorganization during in vivo induction of human T cell tolerance
Ruifeng Li, Huidong Guo, Yingping Hou, Shuoshuo Liu, Ming Wang, Ting Peng, Xiang‐Yu Zhao, Liming Lu, Yali Han, Yiming Shao et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
In vivo CRISPR screening identifies Fli1 as a transcriptional safeguard that restrains effector CD8 T cell differentiation during infection and cancer
Zeyu Chen, Eri Arai, Omar Khan, Zhen Zhang, Shin Foong Ngiow, Yuan Ming He, Hua Huang, Sasikanth Manne, Zhendong Cao, Amy E. Baxter et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
Ketolysis is a metabolic driver of CD8 + T cell effector function through histone acetylation
Katarzyna Müller Luda, Susan M. Kitchen-Goosen, Eric H. Ma, McLane J. Watson, Lauren R. Duimstra, Brandon M. Oswald, Joseph Longo, Zhen Fu, Zachary Madaj, Ariana Kupai et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
Rational Combinatorial Targeting by Adapter CAR T Cells (AdCAR-T) Prevents Antigen Escape in Acute Myeloid Leukemia (AML)
Daniel Atar, Lara Ruoff, Anna‐Sophia Mast, Simon Krost, Moustafa Moustafa-Oglou, Sophia Scheuermann, Beate Kristmann, Maximilian Feige, Aysegül Canak, Katrin Wolsing et al. · 2023 · Research Square
Reinvigoration of translational activity in dysfunctional T cells initiates the early intratumoral response to PD-1 blockade
Paulien Kaptein, Nadine Slingerland, Anne M. van der Leun, Eline Runderkamp, Roos A. Wagensveld, Sherman Michael Chin, Janniek R. Mors, Mercedes Machuca-Ostos, Timm M. Reißig, Kelly Dare Moynihan et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
Reversible control of T cell exhaustion by NR4A transcription factors revealed through targeted protein degradation
Erik Ehinger, Kristy C. Perez, Emi Sanchez, Bruno Villalobos Reveles, Barsha Dash, Leo J. Arteaga-Vazquez, Eric Johnson, Anjana Rao, Patrick G. Hogan · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
Systems immunology meets epigenetics
Wenhui Li, Ziyi Chen, Aiping Wu, Frank Xiao-Feng Qin, Lianjun Zhang · 2020 · Elsevier eBooks
Charting a shared epigenetic pathway to CD8+ T cell dysfunction in infection and cancer
Katalin D. Sandor, Bence Dániel, Ansuman T. Satpathy · 2021 · Molecular Cell
CIMT 2021: report on the 18th Annual Meeting of the Association for Cancer Immunotherapy
Arne Billmeier, Krutika Khinvasara, Franziska Lang, Julia Mohr, Daniel Reidenbach, Maik Schork, Ikra Yildiz, Mustafa Diken · 2022 · Human Vaccines & Immunotherapeutics
The Functional Adaptability of Hyporesponsive T Cells and Its Impact on Transplant Outcomes
Dawei Zou, Xiaolong Zhang, Wenhao Chen · 2023 · Current Transplantation Reports
Blocking Co-inhibitory Receptors: A Promising Cancer Immunotherapy strategy
Nandini Acharya · 2024 · Interdisciplinary biotechnological advances
Identification of CDKN3 overexpression as a marker of poor prognosis and potential therapeutic target in low-grade glioma
Hongbing Cheng, Meng Xiao, Yanhua Zhang, Pu Wang, Yucheng Lu · 2025 · Scientific Reports
MEK-dependent bioenergetic demand drives terminal CD8+ T cell exhaustion
Tanya Mitra, Jahan A. Rahman, Madeline A. Hwee, Yan-Ting Chen, Ruben Jose Jesus Faustino Ramos, Hui Liu, Travis E. Hartman, Justin R. Cross, Miguel de Jesus, Morgan Huse et al. · 2026 · Immunity
Self‐Promoting Targeted Delivery of Epigenetic Immunostimulants to Activate Breast Cancer Immunity via HDACs Downregulation and PD‐L1 Upregulation
Xiayun Chen, Lichong Lu, Ziqi Liang, Baixue Yu, Zhouchuan Shao, Jianqiao Li, Yi Cen, Yibin Liu, Shiying Li, Xiaoyuan Shawn Chen · 2025 · Angewandte Chemie
EZH2 in digestive system cancers: Epigenetic regulation, oncogenic interactions, and therapeutic potential
Ahmed M. Hjazi, Ahmed Hussn, Ali Kamil Kareem, Mohammad Yahya Alshahrani, H. Malathi, Priya Priyadarshini Nayak, Ashish Singh Chauhan, Jatin Sharma · 2025 · Experimental Cell Research
Regenerative Immunotherapy for Cancer: Transcription Factor Reprogramming of Tumor-Specific T Cells
Tyler R. McCaw, Nicholas P. Restifo, Kathrin Plath, Joseph Garfield Crompton · 2025 · Cancers
Mapping Current Research Status and Emerging Frontiers of T-Cell Exhaustion: A Comprehensive Data-Mining-Based Study
Pengcheng Li, Qiang Guo, Yanfeng Gao, Wanqing Li, Haiyang Wu · 2025 · Annals of Surgical Oncology
Stem-like CD4+ T cells mediate T-cell state transitions to enhance tumor control and immunotherapy response
Mamali Das, Chandramohan Kiruthiga, K. T. Nachammai, Dipali Desai, William Chi Shing Cho, Chandrabose Selvaraj, Langeswaran Kulanthaivel · 2025 · International Immunopharmacology
Neoadjuvant Immunotherapy in Hormone Receptor-Positive Breast Cancer: From Tumor Microenvironment Reprogramming to Combination Therapy Strategies
Zimei Tang, Tao Huang, Ting-Lin Yang · 2025 · International Journal of Molecular Sciences
Peripheral Immune Remodeling After Spinal Cord Injury
Naomi Veeningen, Ana Laura Añé-Kourí, A. Pues, Serina Rubio, Judith Fraussen, Charalampia Ioannou, Dries S. Martens, Charlotte C. M. van Laake‐Geelen, Jens Deckers, Erwin M. J. Cornips et al. · 2026 · Neurology Neuroimmunology & Neuroinflammation
Drug Development in Non-Oncogene-Addicted Non-Small Cell Lung Cancer
Pedro Cruz, Cristina Boixareu, D. Silva, Joshua Ting, Rayssa Helena Rosa Sena, Steph A. Pang, Stephanie Mullings, Anna Minchom · 2026 · Cancers
Post‐Translational Regulation of CD8 + T Cell Fate and Dysfunction in Tumor Immunity
Zihao Zhou, Xi Chen, Nina Li, Meiyan Zou, Yunfan Lin, Pei Lin, Weiyao Feng, Xinyuan Zhao, Li Cui · 2026 · Advanced Science
The Role of One‐Carbon Metabolism in Cancer and Its Therapeutic Significance
Yuting Jiang, Guoliang Zhou, Qian Zhang, Shengtao Zhou · 2026 · MedComm – Oncology
The AICL-KLRF1 axis supports CD4-CD8 T cell communication and cytokine competence in pre-exhausted CD8+ T cells
Matthias Barone, Stefan Peidli, Anika Neuschulz, Karla Riesterer, Christina Iwert, Laia Junquera, Somesh Sai, Olufemi Bolaji, Diana Bakoueva, Christine Appelt et al. · 2026 · EMBO Reports
Engineered MSCs enable bone marrow-targeted immunomodulation
Shuyue Xu, Jingwen Xu, Qiqi Yang, Ju Zeng, Mengjie Zhang, Yuge Wu, Zhen Liu, Qun Wang, Qing You, Shiyi Zhang · 2026 · Cell stem cell
SELL Marks an Effector‐Deficient CD8 + T Cell Subset That Promotes Intracerebral Hemorrhage and Responds to Rutin Therapy
Yan Huang, Haochen Xu, Congxia Bai, Jing Liu, Yingying Sun, Jingzhou Chen · 2026 · Human Mutation
Enzyme-Triggered Self-Immobilization of an NIR Prodrug for Tumor-Selective Cancer Vaccination
Yuyao Li, Hongze Ren, Jiayi Feng, Xiaochuan Shan, Chaoying Zhang, Jin Nan, Zhengqi Tang, Xueqin Ding, Meihua Yu, Hexin Xie et al. · 2026 · Journal of the American Chemical Society
Dendritic cell-driven immune rebalancing as a systemic regulator of tumor and neurodegenerative microenvironments
Peng-Yu Zhao, Kai‐Kai Wang, Meng-Meng Zhang, Ze-Lin Cao, Wei-Lin Jin, Wioletta Rozpędek‐Kamińska · 2026 · Critical Reviews in Oncology/Hematology
Epigenetic plasticity in cancer drug resistance: mechanistic insights and strategies for therapeutic intervention
Wei Zhao (14321), Jing-xuan Pan · 2026 · Acta Pharmacologica Sinica
Vaccination-enabled immune readiness for checkpoint blockade
Jhommara Bautista, Andrés López-Cortés · 2026 · Frontiers in Immunology
Targeting T-cell exhaustion and tumour immune evasion: a review of emerging strategies
Leticija Saltis, Liew Jun Mun · 2026 · Pathology - Research and Practice
Post‑translational modification‑governed immune states in cancer immunity: Biomarker implications for checkpoint competence, tumor visibility and immunotherapy resistance (Review)
Jinghao Pan, Boyang Li, Ruonan Lin, Chenlu Fang, Lucy Lau, Zehao Hong, Yi Chen · 2026 · International Journal of Oncology
Chimeric Antigen Receptor (CAR) Redirected T Cells
Astrid Holzinger, Hinrich Abken · 2020 · Learning materials in biosciences
Advances in research on glioma microenvironment and immunotherapeutic targets
Aiwei Tang, Jianhao Liang, Yiying Mai, Haitao Sun · 2022 · Journal of Cancer Discovery
Tumor Microenvironment Complexity: A Pathological Milieu that Innately Modulates Cancer Progression
Liliana-Roxana Balahura, Andreea Daniela Lazăr, Sorina Dinescu, Marieta Costache · 2022 · Springer eBooks
Advancing Cancer Immunotherapy Through Integrating Molecular and Computational Approaches
Reem A. Elghaish, Zina Alaswad, Sondos H. Abdelhafeez, Omar Salem, Menattallah Elserafy · 2023 · Springer eBooks
De novo priming: driver of immunotherapy responses or epiphenomenon?
Alexander L. Young, Tara Lorimer, Sarwah Al-Khalidi, Edward W. Roberts · 2023 · Essays in Biochemistry
Epigenetic priming—fact or falacy?
Maria Victoria Revuelta, Leandro C. A. Cerchietti · 2023 · Elsevier eBooks
The effect of chemotherapies on the crosstalk interaction between CD8 cytotoxic T-cells and MHC-I peptides in the microenvironment of WHO grade 4 astrocytoma
Nadeem Shafique Butt, Maryam Enani, Maryam Alshanqiti, Alaa Alkhotani, Taghreed Alsinani, Mohammed Matoog Karami, Motaz M. Fadul, Majid Almansouri, Amber Hassan, Saleh Salem Baeesa et al. · 2023 · Folia Neuropathologica
Concomitant Use of Steroids and Immunotherapy in a Patient With Paraneoplastic Dermatomyositis and Gastroesophageal Adenocarcinoma
Fernando Poli de Frias, Ryan Petit, Carlos Peña, Francesca Polit, Robert Poppiti, Carlos A. Sesin · 2023 · Cureus
Appraisal of Proximate Composition in Tiger Nut Yogurts and Selected Commercially Available Yogurts in Enugu, Enugu State, Nigeria: A Comparative Study
O. T. Onuigbo, Joy Ugo Nwamarah, Emeka Oparaji, A. C. Onuigbo, B. O. Ogwo · 2024 · Journal of Applied Life Sciences International
Adjuvant PD-1 Checkpoint Inhibition in Early Cutaneous Melanoma: Immunological Mode of Action and the Role of Ultraviolet Radiation
Matthias Brandlmaier, Magdalena Hoellwerth, Peter Koelblinger, Roland Lang, Andrea Harrer · 2024 · Cancers
Cancer Cell Small Molecule Secretome Induces the Immune Checkpoint NKG2A and Dysfunction of Human CD8+ T Cells
Gabriel J Rodriguez-Garcia, Diana K. Graves, Muhammad Bilal Mirza, Kamran Idrees, Young Jin Kim, Michael J. Korrer, Jeffrey C. Rathmell · 2024 · ImmunoHorizons
Tight Interplay Between Therapeutic Monoclonal Antibodies and the Tumour Microenvironment in Cancer Therapy
Quentin Riller, Aditi Varthaman, Sophie Sibéril · 2020 · Advances in experimental medicine and biology
Un repos intermittent des cellules CAR-T améliore leur efficacité thérapeutique
Marine Sroussi, Edith Rosado · 2022 · médecine/sciences
The Mechanisms of CD8+ T Cells Exhaustion in the Tumor Microenvironment and Immune Therapy
Haiyuan An, Shiqi Song, Jian Yuan Huang · 2023 · Journal of Cancer Therapy
Impaired tumor death receptor signaling drives resistance to CAR T cell therapy
Nathan Singh, Olga E. Shestova, Pranali Ravikumar, Katharina E. Hayer, Seok Jae Hong, Elena J. Orlando, Karen Thudium Mueller, Charly Ryan Good, Shelley L. Berger, Ophir Shalem et al. · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
Semaphorin 3A induces cytoskeletal paralysis in tumor-specific CD8+ T cells
Mike Bogetofte Barnkob, Yale S. Michaels, Violaine André, Philip S. Macklin, Uzi Gileadi, Salvatore Valvo, Margarida Rei, Corinna A. Kulicke, Ji‐Li Chen, Vitul Jain et al. · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
Editorial: T cell exhaustion; mechanisms of induction, modulation, and recovery
Mohamed S. Abdel-Hakeem · 2023 · Frontiers in Immunology
Decoupling the correlation between cytotoxic and exhausted T lymphocyte transcriptomic signatures enhances melanoma immunotherapy response prediction from tumor expression
Binbin Wang, Kun Wang, Peng Jiang, Eytan Ruppin · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
Extra-islet expression of islet antigen boosts T-cell exhaustion to prevent autoimmune diabetes
Claudia Selck, Gaurang Jhala, David J. De George, Chun-Ting J. Kwong, Marie K. Christensen, Evan G. Pappas, Xin Liu, Tingting Ge, Prerak Trivedi, Axel Kallies et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
Temporal genomic analysis of melanoma rejection identifies regulators of tumor immune evasion
Sapir Cohen Shvefel, Joy A. Pai, Yingying Cao, Lipika R. Pal, Ronen Levy, Winnie Yao, Kuoyuan Cheng, Marie J. Zemanek, Osnat Bartok, Chen Weller et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
Different signaling interpretations by PKC eta and theta control T cell function and exhaustion
Thomas H. Mann, Hannah M. Knox, Shixin Ma, Jesse Furgiuele, Anna-Maria Globig, Michael A. LaPorta, H. Kay Chung, Bryan McDonald, Majid Ghassemian, Steven Zhao et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
TCF1 lo CD8 T cells proliferate and persist autonomously in tumors
Megan M. Erwin, Natalie R. Favret, Claudia N. McDavid, Zachary D. Ewell, Melissa M. Wolf, Lincoln A. Brown, Jessica J. Roetman, Michael W. Rudloff, Kristen A. Murray, Carlos R. Detrés Román et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
Cysteine reactivity profiling links metabolic rewiring to the dysfunctional human T cell proteome
Hiroyuki Kojima, Charlotte R. Wayne, Luis F. Somarribas Patterson, Henry Sanford, Tzu-Jou Chen, Ya-Hui Lin, Joshua David Schoenfeld, Lisa H.F. McGary, Yanting Chen, Korbinian Nepomuk Kropp et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
ITPKB is a Conserved Regulator of Natural Killer Cell Desensitization/education that Constrains Antitumor Immunity
Yeara Jo, Alexandros Karampatzakis, Seung Won Lee, Alice Peng, Zaina Ghouri, Monsserratt Moya, Elizabeth Andrews, Harrison Sudholz, Chenyu Zhang, Berna Bou Tayeh et al. · 2026 · SSRN Electronic Journal
Defining Neoepitopes that Contribute to Tumor Immunity
Cory A Brennick · 2018 · OpenCommons - UConn (University of Connecticut)
rPCMP: robust p-value combination by multiple partitions with applications to ATAC-seq data
Menglan Cai, Limin Li · 2018 · BMC Systems Biology
MicroRNA-21 Regulates Metabolic Adaptation of Pathogenic TH17 cells and Controls Autoimmune Inflammation
Xiang Yu, Li Wang, Chao Yao, Rong Qiu, Yange Cui, D. Dai, Jun Deng, Guo-Jun Hou, Yan Wang, J. Qian et al. · 2017 · bioRxiv
New approaches to induce tolerance in autoantigen-specific memory T cells in type 1 diabetes
Claudia Selck · 2018 · Minerva Access (University of Melbourne)
Intracellular expression of Fas Ligand and Granzyme B by tumor infiltrating or in vitro activated CD8+ T cell populations
Amanda N. Scott · 2019 · ERA: Education and Research Archive (University of Alberta)
CAR T-Cell Therapy for CNS Malignancies
Khaled S. Sanber, Sujith K. Joseph, Nabil M. Ahmed · 2019 · Elsevier eBooks